Development and comprehensive evaluation of Tetronic® 1304-Labrasol® mixed micelles for lung-targeted drug delivery: A physicochemical, biological, and computational approach for improved pulmonary chemotherapy | Synapse
March 3, 2026
Development and comprehensive evaluation of Tetronic® 1304-Labrasol® mixed micelles for lung-targeted drug delivery: A physicochemical, biological, and computational approach for improved pulmonary chemotherapy
Key Points
Improved efficiency in delivering drugs using mixed micelles demonstrates significant potential for enhancing pulmonary chemotherapy.
The physicochemical properties of the mixed micelles were thoroughly evaluated, showing promising characteristics for drug delivery.
Biological evaluation indicates enhanced targeting capabilities, supporting the utility of this method in lung treatments.
Implications highlight the need for expanded research to validate efficacy in clinical scenarios, with further studies warranted.